The effect of baricitinib on daily and workplace activity from phase 3 trials BREEZE-AD1 and BREEZE-AD2 in adult patients with moderate to severe atopic dermatitis

被引：0

作者：

Eichenfield, Lawrence F. ^{[1
,2
]}

Silverberg, Jonathan I. ^{[3
]}

Carrascosa, Jose-Manuel ^{[4
]}

Rubel, Diana ^{[5
]}

Watts, Steven ^{[5
]}

Casillas, Marta ^{[6
]}

DeLozier, Amy M. ^{[6
]}

Pierce, Evangeline ^{[6
]}

机构：

[1] Univ Calif San Diego, San Diego, CA 92103 USA

[2] Rady Childrens Hosp, San Diego, CA USA

[3] George Washington Univ, Sch Med, Washington, DC 20052 USA

[4] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona, Spain

[5] Australian Natl Univ, Woden Dermatol, Canberra, ACT, Australia

[6] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

15058

引用

页码：AB140 / AB140

页数：1